Trustmark National Bank Trust Department raised its position in MetLife, Inc. (NYSE:MET) by 10.5% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 42,407 shares of the financial services provider’s stock after buying an additional 4,013 shares during the period. Trustmark National Bank Trust Department’s holdings in MetLife were worth $2,330,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of the stock. Prudential Financial Inc. lifted its stake in MetLife by 71.4% in the 2nd quarter. Prudential Financial Inc. now owns 3,672,729 shares of the financial services provider’s stock worth $201,778,000 after purchasing an additional 1,529,570 shares in the last quarter. Schwab Charles Investment Management Inc. lifted its stake in MetLife by 5.2% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,555,656 shares of the financial services provider’s stock worth $195,348,000 after purchasing an additional 175,311 shares in the last quarter. Teacher Retirement System of Texas lifted its stake in MetLife by 7.2% in the 1st quarter. Teacher Retirement System of Texas now owns 822,785 shares of the financial services provider’s stock worth $43,460,000 after purchasing an additional 55,508 shares in the last quarter. KBC Group NV lifted its stake in MetLife by 14.3% in the 2nd quarter. KBC Group NV now owns 1,263,802 shares of the financial services provider’s stock worth $69,433,000 after purchasing an additional 157,734 shares in the last quarter. Finally, Boston Partners lifted its stake in MetLife by 0.5% in the 2nd quarter. Boston Partners now owns 2,010,623 shares of the financial services provider’s stock worth $110,464,000 after purchasing an additional 9,845 shares in the last quarter. Institutional investors own 74.27% of the company’s stock.

WARNING: “MetLife, Inc. (MET) Shares Bought by Trustmark National Bank Trust Department” was first posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this article on another publication, it was illegally stolen and republished in violation of US and international copyright and trademark laws. The original version of this article can be viewed at https://www.thecerbatgem.com/2017/09/30/metlife-inc-met-shares-bought-by-trustmark-national-bank-trust-department.html.

Shares of MetLife, Inc. (MET) opened at 51.95 on Friday. The stock has a market cap of $55.22 billion, a price-to-earnings ratio of 611.18 and a beta of 1.44. MetLife, Inc. has a 52-week low of $38.17 and a 52-week high of $51.97. The stock’s 50 day moving average is $47.80 and its 200 day moving average is $47.30.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.02. The business had revenue of $17.39 billion for the quarter, compared to the consensus estimate of $17.11 billion. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The company’s quarterly revenue was up 2.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.83 earnings per share. On average, equities analysts expect that MetLife, Inc. will post $4.82 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 13th. Investors of record on Monday, August 7th were paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 3.08%. The ex-dividend date was Thursday, August 3rd. MetLife’s payout ratio is 1,777.98%.

A number of research analysts have weighed in on the stock. ValuEngine raised shares of MetLife from a “buy” rating to a “strong-buy” rating in a research note on Tuesday. Royal Bank Of Canada reissued a “buy” rating and issued a $56.00 target price on shares of MetLife in a research note on Wednesday, September 6th. UBS AG reissued a “neutral” rating and issued a $49.00 target price (down from $57.00) on shares of MetLife in a research note on Friday, September 1st. FBR & Co reissued a “buy” rating and issued a $53.00 target price on shares of MetLife in a research note on Tuesday, August 29th. Finally, Credit Suisse Group reissued a “neutral” rating and issued a $53.00 target price (down from $64.00) on shares of MetLife in a research note on Monday, August 28th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $57.95.

About MetLife

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.